TheraB Medical to Present at the 36th Annual Michigan Growth Capital Symposium and Coulter Investment Forum May 16-17, 2017
National investment community and nation’s leading entrepreneurs expected at University of Michigan’s premier venture fair
National investment community and nation’s leading entrepreneurs expected at University of Michigan’s premier venture fair
ANN ARBOR, MICH. (May, 2017)– TheraB Medical today announced that it has been selected to present at the 36th annual Michigan Growth Capital Symposium (MGCS) and the jointly hosted Coulter Investment Forum. The company, which launched in East Lansing in 2014, will present to investors in attendance, which represent more than 100 top venture capital firms.
First held in 1981, MGCS is the premier, must-attend event for venture capitalists, technology transfer professionals, founders, CEOs and the best of the Midwest early stage and emerging, high-growth companies that are seeking institutional investment. The two-day conference will feature keynote addresses from Clay Thorp, general partner of Hatteras Venture Partners, and Markus Lampinen, CEO of Crowd Valley, along with engaging panel discussions and unmatched networking opportunities for attendees.
TheraB Medical is a pre-market startup focused on launching SnugLit— a wearable, portable solution to infant jaundice that promotes parental-infant bonding and breastfeeding. SnugLit is designed to be worn by the infant, facilitating closeness and allowing the mother to freely hold, breastfeed, and bond with her baby. It provides 360-degree blue light coverage in an all-in-one device – nearly twice the coverage of traditional treatments. Founded in 2014 by 3 engineering students, SnugLit is being developed in partnership with over 200 medical professionals across Michigan. The company is currently raising a $500,000 seed round.
“As a company who has grown up in Michigan, we are greatly looking forward to pitching SnugLit and meeting with investors from across the state and other areas of the midwest,” said the company’s CEO and Co-Founder, Alexa Jones.
More than 500 entrepreneurs, researchers, investment professionals and business executives are expected to attend the Symposium, which will be held May 16-17 at the Marriott Resort in Ypsilanti, Mich. The evening reception on the opening day of the conference at the University of Michigan’s football stadium will provide attendees the chance to network on and off the field.
“The Symposium plays a vital role in the Midwest’s entrepreneurial ecosystem, creating a platform for high-growth companies to make their case to investors and access new sources of funding,” said David Brophy, Michigan Growth Capital Symposium founder and director of the University of Michigan’s Center for Venture Capital & Private Equity. “I am continually impressed by the caliber of companies that join us to present year after year, and we are glad to have TheraB Medical join the ranks for this year’s special joint event with the Coulter Investment Forum.”
To learn more, see the full list of presenting companies or register for the conference, visit www.michigan-gcs.com and follow conversations about the Symposium by tracking #MichiganGCS on Twitter. For more information about TheraB Medical, please visit www.therabmedical.com.
About TheraB Medical
TheraB Medical is a startup working to launch its first product, SnugLit. SnugLit is a wearable, portable solution to infant jaundice that promotes maternal-infant bonding and breastfeeding while covering nearly twice the surface area of traditional methods. Founded in 2014 by 3 engineering students, SnugLit is being developed in partnership with over 200 medical professionals across Michigan. The company is currently raising a $500,000 seed round.
About the Michigan Growth Capital Symposium
The Michigan Growth Capital Symposium (MGCS) is the original university-based venture investment fair, which was first held in 1981. This decades-old nationally attended event is the largest Midwest fair of its kind that brings together venture capital investors, business angels, start-up companies, university tech transfer officers and research faculty. MGCS provides an opportunity for participants from the venture capital community to connect with Midwest start-ups seeking funding and to learn about emerging innovations that span tech and the life sciences. MGCS is presented by the Center for Venture Capital & Private Equity Finance and the Zell Lurie Institute at the University of Michigan Ross School of Business, with support from the Michigan Venture Capital Association.
First held in 1981, MGCS is the premier, must-attend event for venture capitalists, technology transfer professionals, founders, CEOs and the best of the Midwest early stage and emerging, high-growth companies that are seeking institutional investment. The two-day conference will feature keynote addresses from Clay Thorp, general partner of Hatteras Venture Partners, and Markus Lampinen, CEO of Crowd Valley, along with engaging panel discussions and unmatched networking opportunities for attendees.
TheraB Medical is a pre-market startup focused on launching SnugLit— a wearable, portable solution to infant jaundice that promotes parental-infant bonding and breastfeeding. SnugLit is designed to be worn by the infant, facilitating closeness and allowing the mother to freely hold, breastfeed, and bond with her baby. It provides 360-degree blue light coverage in an all-in-one device – nearly twice the coverage of traditional treatments. Founded in 2014 by 3 engineering students, SnugLit is being developed in partnership with over 200 medical professionals across Michigan. The company is currently raising a $500,000 seed round.
“As a company who has grown up in Michigan, we are greatly looking forward to pitching SnugLit and meeting with investors from across the state and other areas of the midwest,” said the company’s CEO and Co-Founder, Alexa Jones.
More than 500 entrepreneurs, researchers, investment professionals and business executives are expected to attend the Symposium, which will be held May 16-17 at the Marriott Resort in Ypsilanti, Mich. The evening reception on the opening day of the conference at the University of Michigan’s football stadium will provide attendees the chance to network on and off the field.
“The Symposium plays a vital role in the Midwest’s entrepreneurial ecosystem, creating a platform for high-growth companies to make their case to investors and access new sources of funding,” said David Brophy, Michigan Growth Capital Symposium founder and director of the University of Michigan’s Center for Venture Capital & Private Equity. “I am continually impressed by the caliber of companies that join us to present year after year, and we are glad to have TheraB Medical join the ranks for this year’s special joint event with the Coulter Investment Forum.”
To learn more, see the full list of presenting companies or register for the conference, visit www.michigan-gcs.com and follow conversations about the Symposium by tracking #MichiganGCS on Twitter. For more information about TheraB Medical, please visit www.therabmedical.com.
About TheraB Medical
TheraB Medical is a startup working to launch its first product, SnugLit. SnugLit is a wearable, portable solution to infant jaundice that promotes maternal-infant bonding and breastfeeding while covering nearly twice the surface area of traditional methods. Founded in 2014 by 3 engineering students, SnugLit is being developed in partnership with over 200 medical professionals across Michigan. The company is currently raising a $500,000 seed round.
About the Michigan Growth Capital Symposium
The Michigan Growth Capital Symposium (MGCS) is the original university-based venture investment fair, which was first held in 1981. This decades-old nationally attended event is the largest Midwest fair of its kind that brings together venture capital investors, business angels, start-up companies, university tech transfer officers and research faculty. MGCS provides an opportunity for participants from the venture capital community to connect with Midwest start-ups seeking funding and to learn about emerging innovations that span tech and the life sciences. MGCS is presented by the Center for Venture Capital & Private Equity Finance and the Zell Lurie Institute at the University of Michigan Ross School of Business, with support from the Michigan Venture Capital Association.